Otsuka Holdings のニュースと活動

Otsuka Holdingsはの一部です...

• Forbes Global 2000 (#654);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

％sは、株式相場表示 ％s（％s）の下にリストされている会社です。

Otsuka Holdings は 11 の国に直接拠点を置いています。

Otsuka HoldingsはAraris Biotech,Cambridge Isotope Laboratories,Interpharmaを含む23の子会社があります。

彼らはにいます：

• 医薬品46%
• 医療機器29%
• その他25%

263人の主要幹部と一緒に組織図を見る

Otsuka Holdingsでもっとも検索された略歴

• Makoto Inoue, President and Representative Director, Chief Executi...
• Yukio Matsutani, Independent Director
• Jiro Seguchi, Outside Director and Board Member

アラートを作成
Otsuka Holdings のエグゼクティブの異動をフォローします。

Otsuka HoldingsはUnitedHealth Group (アメリカ合衆国（米国）),Kaiser Permanente (アメリカ合衆国（米国）),HCA (アメリカ合衆国（米国）)を含む3,511の競合企業を有します。

Popular M&A news in 保健・医療

• ％sは、％s百万ドルの資金調達を発表しました。 (2026年6月4日に公開).
• ％2$sは％1 $ sを取得しました (2026年6月2日に公開).
• ％2$sは％1 $ sを取得しました (2026年6月2日に公開).

保健・医療業界でのその他のコンタクトの提案

• IQVIA 社 Ari Bousbib - Chairman and Chief Executive Officer
• Kaiser Permanente 社 Gregory Adams - Chief Executive Officer and Chairman of the Board
• Royalty Pharma 社 Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer

保健・医療業界についてさらに知る

％sによる最新のプレスリリース

• Otsuka Signs Joint Research Agreement with Keio UniversityIndustry-academia collaboration for infrastructure development toward the social implementation of psychedelics in Japan ｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy SupplementsFacilitating the Research and Development of Gummy Products｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical Opens First POCARI SWEAT Factory in VietnamSupporting Health and Meeting Growing Demand｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical is Focusing on "Water, Nutrition, and Oxygen" to Tap into Human PotentialProvide "Wellness Energy" at Expo 2025 in Osaka, Kansai, Japan｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical is Expanding "Local Production and Local Recycling" of PET Bottle Initiatives in Cooperation with Local CommunitiesAgreement Signed with the Saga Eastern Environmental Facilities Association for Horizontal Recycling of PET Bottle｜New
• Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Is Now on Sale - Insurance coverage begins on March 1, 2025｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical Finalizes an Agreement with Fukuroi City on the Horizontal Recycling of PET BottlesPartnering with Its Factory to Promote a "Local Production and Local Recycling" Initiative for PET Bottles｜News Releases | Otsuka Pharmaceutical Co.,
• Otsuka Sponsor TOKYO MARATHON 2025 Supporting the Conditioning of Runners Worldwide with the Global Brand POCARI SWEAT｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• View more press releases Close

％sについてのソーシャルメディア

• Otsuka Holdings についてのウィキペディア,Google News & Yahoo Financeの記事
• Otsuka Holdings についてのLinkedIn,ツイッター & YouTubeの記事